Has Meghan Dermody, MD received payments from drug or device companies?

Yes. Drug and device makers reported $103,164 in general payments to Meghan Dermody, MD across 223 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meghan Dermody, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meghan Dermody, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meghan Dermody, MD

Vascular Surgery · Lancaster, PANPI 1265552608

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Silk Road Medical, Inc. accounts for 60.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $31,741 and has fallen 54.5% since, to $14,435 in 2025. Among vascular surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$103,164in general payments, 2019–2025

Across 223 payments — averaging $462.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Silk Road Medical, Inc.$62K
Medtronic$33K
Shockwave Medical, Inc$5K
W. L. Gore & Associates, Inc.$1K
Boston Scientific$678
Philips North America LLC$426
plus $1K from 12 others

$217,807in research payments, 2019–2025

Across 52 payments — averaging $4188.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$150K
Silk Road Medical, Inc.$56K
Boston Scientific$12K

What the payments were for

Consulting fees$50,69449%
Speaking & faculty fees$24,48824%
Grants$670%
Travel & lodging$20,65920%
Food & beverage$7,2027%
Education$240%
Entertainment$310%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Silk Road Medical, Inc.	103	$62,100
Medtronic(2 entities)	72	$33,028
Shockwave Medical, Inc	6	$4,575
W. L. Gore & Associates, Inc.	13	$1,006
Boston Scientific	5	$678
Philips North America LLC	2	$426
Penumbra, Inc.	3	$422
Cook Medical LLC	4	$416
Surmodics, Inc.	3	$209
Cagent Vascular Inc	1	$53
Tactile Systems Technology Inc	2	$50
Haemonetics Corporation	1	$43
Bard Peripheral Vascular, Inc.	2	$41
Inari Medical, Inc.	2	$34
Janssen Scientific Affairs, LLC	1	$27
Medline Industries LP	1	$22
Lemaitre Vascular, Inc.	1	$21
Endologix LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,164 in reported general payments places this provider in the 95th percentile of 236 vascular surgery providers in Pennsylvania.

See all vascular surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$154,004

Medicare patients

590

Services billed

1,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	19	$10,527
XareltoRivaroxaban	12	$9,758
ClopidogrelClopidogrel Bisulfate	65	$722
Cilostazol	14	$110
Atorvastatin Calcium	18	$97

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lancaster

David CziperleLancaster$37K
Thomas O ConnorLancaster$14K
Darren SchneiderPhiladelphia$569K
Elizabeth GenovesePhiladelphia$343K
Shang LohPhiladelphia$306K
Paul FoleyDoylestown$241K
Michel MakarounPittsburgh$143K
Robert MeisnerLebanon$128K
Vincent DigiovanniMedia$127K
Efthymios AvgerinosPittsburgh$120K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →